HANSHOW
28.2.2024 10:59:29 CET | Business Wire | Press release
Hanshow, a leader in retail technology innovation, today unveiled a series of Green Store Solutions, designed to accelerate the retail industry towards a sustainable future. Complementing this new product, Hanshow has also released a comprehensive Green Digitalization Report alongside tech partners Microsoft, Intel, and E Ink.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240223583112/en/
Hanshow at EuroCIS 2024 (Photo: Business Wire)
The Polaris Pro Electronic Shelf Labels (ESL) series stands out with its high screen-to-body ratio, multi-color display capabilities, and user-replaceable battery system designed for longevity, embodying Hanshow's commitment to sustainability. This advanced ESL solution is set to reduce paper waste, improve pricing accuracy, and enhance the overall aesthetic of modern retail environments.
Building on the innovative leadership of the Polaris Pro, Hanshow's Green Store Solutions extend beyond ESLs to include dynamic in-store marketing and AI-driven solutions. These innovations optimize store performance through targeted promotions, precise inventory management, and real-time data insights, facilitating smarter, greener operations.
To push the boundaries of what is possible in retail further, Hanshow integrates GenAI technology into its digital retail Solutions, enhancing operational efficiency and customer experiences. This adoption of GenAI simplifies complex processes and decision-making, making retail operations more efficient and intuitive. GenAI serves as an assistant to both store associates and customers, enabling easier navigation, personalized shopping experiences, and enhanced staff productivity.
Hanshow’s authoritative Green Digitalization Report, highlighting the dual benefits of digitalization and sustainability. The report, produced in cooperation with Microsoft, Intel, and E Ink, offers a deep dive into how retailers can use green digitalization as a double engine for growth, marrying eco-efficiency with cutting-edge innovation.
"Hanshow is proud to be at the forefront of the movement towards a greener, more digital future for retail," said Liangyan Li, SVP and Head of Global Sales at Hanshow. "With the introduction of the Polaris Pro series and our comprehensive Green Store Solutions, including our pioneering work on GenAI, we are paving the way for retailers to operate sustainably without compromising on customer satisfaction or operational excellence."
To further promote the many exciting ways in tech technology is laying a stronger foundation for sustainability in the retail industry, Hanshow’s Green Digitalization Report outlines actionable strategies to integrate sustainability into core business operations through innovative technologies. The report was released jointly with important contributions from industry partners such as Microsoft, Intel, and E Ink, and emphasizes myriad ways in which new technological advancements in AI, IOT, and data-driven decision-making will optimize management, reduce resource waste and store costs, improve associates’ work productivity and job satisfaction, and more accurately track and adjust customer experiences both in-store and online, all while helping retailers to meet sustainability targets.
Retailers eager to explore the Polaris Pro series, the suite of Green Store Solutions, and the findings of the Green Digitalization Report are invited to connect with Hanshow's team. Demonstrations and consultations are available to showcase how these initiatives can be seamlessly incorporated into existing retail frameworks.
About Hanshow
Hanshow is one of the global leaders in the development and manufacturing of electronic shelf labels and digital store solutions. The company offers customers a series of customized IoT touchpoints and digital store solutions that deliver customer-centric insights. Hanshow's solutions have provided services to a vast number of stores across more than 50 countries and regions, helping them streamline operations, optimize pricing strategies, and offer consumers a more personalized experience. Learn more: www.hanshow.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223583112/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 15:30:00 CEST | Press release
Quaise's Project Obsidian, a commercial-scale superhot Enhanced Geothermal System (EGS), selected to receive federal funding as part of $99 million DOE effort to advance geothermal energy development across the United States Supports completion of the first well triplet at Project Obsidian, targeting more than 25 megawatts of gross electric power Project team includes Pacific Northwest National Laboratory, Lawrence Berkeley National Laboratory and Oregon State University Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country.
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 15:30:00 CEST | Press release
Late-Breaking Abstract to Feature New Data from First Phase 3 Registrational Study of Arcotatug Tavatecan in Previously Treated Advanced Gastric CancerTAK-928 Presentations Reinforce Potential in Patients with Immunotherapy-Resistant Non-Small Cell Lung Cancer (NSCLC) and Previously Untreated NSCLCTakeda Continues to Progress Clinical Development of Arcotatug Tavatecan and TAK-928; New Non-Squamous NSCLC Sub-Trial Added to Global Phase 3 MarsLight-11 Study Evaluating TAK-928 vs. Docetaxel Monotherapy Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be
From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 15:00:00 CEST | Press release
Colgate-Palmolive builds on its legacy of oral health, publishing an impact evaluation, evolving its health education tools rooted in behavior change, and scaling its global health partnerships. Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and
Citi Wealth’s 2026 Global Family Office Report Reveals Clients Are Shifting Their Focus Towards Public Equities While Becoming More Deliberate and Resilient Amid Uncertainty22.9.2026 14:30:00 CEST | Press release
Public equities have re-emerged as the primary destination for incremental capital Private markets remain a strategic pillar of family office portfolios Artificial intelligence is moving from experimentation toward implementation Cross-border complexity is rising as families become increasingly international Leadership succession and next-generation preparedness are now immediate priorities rather than distant considerations Watch Citi Wealth’s Global Family Office leadership discuss the report’s findings here. Citi Wealth today released its 2026 Global Family Office Report, offering an inside perspective into the thinking and behaviors of the world’s most sophisticated investors. The report was compiled by Citi Wealth’s Global Family Office Group, which works with more than 1,900 family offices worldwide. Conducted in June and July 2026, the survey sheds light on how over 350 family offices in more than 40 countries are navigating new complexities in an era defined by uncertainty. Tod
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio22.9.2026 14:30:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna, Austria. "The breadth of research being presented at EADV 2026 highlights the strength of our Inflammation and Autoimmunity portfolio," said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Data presentations in hidradenitis suppurativa, atopic dermatitis and prurigo nodularis demonstrate our commitment to advancing innovation across immune-mediated skin diseases and deepening our understanding of the patient experience." Details on key Incyte data presentations at EADV include: Oral Presentations Atopic Dermatitis Atopic Dermatitis and Life Course Disruption: Evidence From a Multidimensional International Survey (TOPiQAL) (Session: Free Communication 1: Atopic dermatitis/Eczema. Thursday, October 1, 2:50-3:0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom